Stockreport

How The Rhythm Pharmaceuticals (RYTM) Story Is Evolving After EMANATE And Imcivree Developments [Yahoo! Finance]

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com
PDF Rhythm Pharmaceuticals now carries a Fair Value price target of $137.27, a modest shift from $135.53 that reflects updated assumptions in the latest analyst models. Thi [Read more]